Docetaxel-induced pericardial effusion

Serife E. Dogan; Dilsa Mizrak; Ali Alkan; Ahmet Demirkazik

doi:10.1177/1078155216643859

Docetaxel-induced pericardial effusion

Serife E. Dogan, Dilsa Mizrak, Ali Alkan, Ahmet Demirkazik

GI Medical Oncology

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Abstract

Hypersensitivity reactions, cumulative fluid retention, and neurotoxicity are frequently seen toxicities related to docetaxel. Fluid retention may be present as edema, weight gain, or third place fluid collection. Pericardial effusion is rarely seen with docetaxel treatment. We report a 58-year-old female patient who was presented with pericardial tamponade after three cycles of docetaxel therapy.

Original language	English (US)
Pages (from-to)	389-391
Number of pages	3
Journal	Journal of Oncology Pharmacy Practice
Volume	23
Issue number	5
DOIs	https://doi.org/10.1177/1078155216643859
State	Published - Jul 1 2017

Keywords

Docetaxel
pericardial effusion
side effect

ASJC Scopus subject areas

Oncology
Pharmacology (medical)

Access to Document

10.1177/1078155216643859

Cite this

@article{61b0768238d8427ebcf11500e7ca6339,

title = "Docetaxel-induced pericardial effusion",

abstract = "Hypersensitivity reactions, cumulative fluid retention, and neurotoxicity are frequently seen toxicities related to docetaxel. Fluid retention may be present as edema, weight gain, or third place fluid collection. Pericardial effusion is rarely seen with docetaxel treatment. We report a 58-year-old female patient who was presented with pericardial tamponade after three cycles of docetaxel therapy.",

keywords = "Docetaxel, pericardial effusion, side effect",

author = "Dogan, {Serife E.} and Dilsa Mizrak and Ali Alkan and Ahmet Demirkazik",

note = "Publisher Copyright: {\textcopyright} SAGE Publications.",

year = "2017",

month = jul,

day = "1",

doi = "10.1177/1078155216643859",

language = "English (US)",

volume = "23",

pages = "389--391",

journal = "Journal of Oncology Pharmacy Practice",

issn = "1078-1552",

publisher = "SAGE Publications Ltd",

number = "5",

}

TY - JOUR

T1 - Docetaxel-induced pericardial effusion

AU - Dogan, Serife E.

AU - Mizrak, Dilsa

AU - Alkan, Ali

AU - Demirkazik, Ahmet

N1 - Publisher Copyright: © SAGE Publications.

PY - 2017/7/1

Y1 - 2017/7/1

N2 - Hypersensitivity reactions, cumulative fluid retention, and neurotoxicity are frequently seen toxicities related to docetaxel. Fluid retention may be present as edema, weight gain, or third place fluid collection. Pericardial effusion is rarely seen with docetaxel treatment. We report a 58-year-old female patient who was presented with pericardial tamponade after three cycles of docetaxel therapy.

AB - Hypersensitivity reactions, cumulative fluid retention, and neurotoxicity are frequently seen toxicities related to docetaxel. Fluid retention may be present as edema, weight gain, or third place fluid collection. Pericardial effusion is rarely seen with docetaxel treatment. We report a 58-year-old female patient who was presented with pericardial tamponade after three cycles of docetaxel therapy.

KW - Docetaxel

KW - pericardial effusion

KW - side effect

UR - http://www.scopus.com/inward/record.url?scp=85019551355&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019551355&partnerID=8YFLogxK

U2 - 10.1177/1078155216643859

DO - 10.1177/1078155216643859

M3 - Article

C2 - 27105899

AN - SCOPUS:85019551355

SN - 1078-1552

VL - 23

SP - 389

EP - 391

JO - Journal of Oncology Pharmacy Practice

JF - Journal of Oncology Pharmacy Practice

IS - 5

ER -

Docetaxel-induced pericardial effusion

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this